ZANOTTI, Laura
 Distribuzione geografica
Continente #
NA - Nord America 3.192
AS - Asia 1.307
EU - Europa 1.287
SA - Sud America 177
Continente sconosciuto - Info sul continente non disponibili 91
AF - Africa 31
OC - Oceania 4
Totale 6.089
Nazione #
US - Stati Uniti d'America 3.129
CN - Cina 443
SG - Singapore 408
PL - Polonia 367
UA - Ucraina 177
DE - Germania 175
IT - Italia 167
HK - Hong Kong 159
BR - Brasile 151
FI - Finlandia 101
VN - Vietnam 97
GB - Regno Unito 78
FR - Francia 64
TR - Turchia 43
CA - Canada 38
IE - Irlanda 34
IN - India 34
RU - Federazione Russa 34
BD - Bangladesh 30
SE - Svezia 17
ES - Italia 15
ID - Indonesia 15
IQ - Iraq 14
NL - Olanda 13
AR - Argentina 11
MX - Messico 11
ZA - Sudafrica 10
PK - Pakistan 9
CZ - Repubblica Ceca 7
JP - Giappone 7
KR - Corea 7
UZ - Uzbekistan 7
AT - Austria 6
BG - Bulgaria 6
TW - Taiwan 6
AE - Emirati Arabi Uniti 5
BE - Belgio 5
LT - Lituania 5
SA - Arabia Saudita 5
EC - Ecuador 4
KG - Kirghizistan 4
MA - Marocco 4
NG - Nigeria 4
NI - Nicaragua 4
CL - Cile 3
CR - Costa Rica 3
KE - Kenya 3
PY - Paraguay 3
TN - Tunisia 3
AU - Australia 2
CH - Svizzera 2
CO - Colombia 2
EG - Egitto 2
EU - Europa 2
JM - Giamaica 2
JO - Giordania 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LV - Lettonia 2
MY - Malesia 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BY - Bielorussia 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GD - Grenada 1
IR - Iran 1
LC - Santa Lucia 1
LU - Lussemburgo 1
LY - Libia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TO - Tonga 1
TT - Trinidad e Tobago 1
Totale 6.000
Città #
Warsaw 367
Fairfield 332
Ashburn 316
Singapore 244
Woodbridge 234
Houston 175
Seattle 169
San Jose 155
Chandler 141
Hong Kong 140
Jacksonville 133
Cambridge 117
New York 106
Wilmington 105
Beijing 101
Ann Arbor 93
Dearborn 92
Los Angeles 73
Helsinki 69
The Dalles 67
Princeton 62
Nanjing 41
Brescia 40
Munich 36
Dublin 34
Council Bluffs 33
Istanbul 31
Shanghai 30
Lauterbourg 29
Chicago 26
Dallas 26
San Francisco 26
Des Moines 25
Buffalo 21
Dong Ket 20
Jinan 20
São Paulo 20
Columbus 19
Ho Chi Minh City 19
London 19
Milan 17
Santa Clara 16
Shenyang 16
Toronto 16
Hanoi 14
Orem 14
Turku 14
Central 13
Changsha 13
Moscow 12
Nanchang 12
Rome 12
Hangzhou 11
Hebei 11
Kunming 10
Belo Horizonte 9
Chennai 9
Jiaxing 9
Redondo Beach 9
Stockholm 9
Tianjin 9
Denver 8
Jakarta 8
Paris 8
Poplar 8
San Diego 8
Ankara 7
Guangzhou 7
Montreal 7
Phoenix 7
Boston 6
Brooklyn 6
Falkenstein 6
Lanzhou 6
Monmouth Junction 6
Norwalk 6
Tashkent 6
Zhengzhou 6
Brno 5
Brussels 5
Hefei 5
Johannesburg 5
Lahore 5
Manchester 5
Mexico City 5
Mumbai 5
Sofia 5
Tokyo 5
Vienna 5
Abuja 4
Atlanta 4
Baghdad 4
Bishkek 4
Cape Town 4
Cazzago San Martino 4
Da Nang 4
Frankfurt am Main 4
Leawood 4
Managua 4
Miami 4
Totale 4.276
Nome #
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2916-21. doi: 10.1073/pnas.1222577110. Epub 2013 Jan 28. Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma. Zhao S1, Choi M, Overton JD, Bellone S, Roque DM, Cocco E, Guzzo F, English DP, Varughese J, Gasparrini S, Bortolomai I, Buza N, Hui P, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Carrara L, Pecorelli S, Silasi DA, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Stiegler AL, Mane S, Boggon TJ, Schlessinger J, Lifton RP, Santin AD 365
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues 364
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 288
Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer 217
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 211
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma 205
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. 204
Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma 194
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. 193
Altered immunolocalization of heat-shock proteins in human peri-implant gingiva 191
Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues. 188
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma 183
RERT: A Novel Regression Tree Approach to Predict Extrauterine Disease in Endometrial Carcinoma Patients 180
Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence 177
Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of randomized trials 175
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition 175
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 174
A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination with Eribulin in Triple-Negative Breast Cancers 170
Incidence and relative risk of adverse events of special interest in patients with castration resistant prostate cancer treated with CYP-17 inhibitors: A meta-analysis of published trials 163
Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: Implications for personalized cancer therapy 161
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome 153
The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines 150
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 147
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 146
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 144
The claudin-low subtype of high-grade serous ovarian carcinoma exhibits stem cell features 138
Room-temperature gas sensing based on visible photoluminescence properties of metal oxide nanobelts 121
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients 121
Oxide nanobelts as conductometric gas sensors 115
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients 114
L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma 111
Gas sensitive light emission properties of tin oxide nanobelts 109
Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer Subtypes 100
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 96
Circulating Serum Micro-RNA as Non-Invasive Diagnostic Biomarkers of Endometriosis 73
Development of a diagnostic model based on serum microRNAs for the diagnosis of endometriosis 55
Serum miRNA-based diagnostic models for endometriosis: from discovery to validation 18
Totale 6.089
Categoria #
all - tutte 26.828
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.828


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022294 0 59 5 4 1 15 24 16 11 46 43 70
2022/2023361 57 24 19 25 28 67 3 37 63 4 16 18
2023/2024457 26 11 46 33 23 111 23 36 75 26 8 39
2024/2025705 6 15 7 103 45 85 54 35 72 42 150 91
2025/20261.684 165 166 110 231 209 138 269 61 104 147 64 20
2026/2027108 70 38 0 0 0 0 0 0 0 0 0 0
Totale 6.089